Macknoll Pharmaceuticals Private Limited

Macknoll Pharmaceuticals Private Limited - trading in Nagpur, Maharashtra, India. FY 2026 financials & compliance.
CIN U24239MH2010PTC205875 Incorporated 23 July 2010 ROC Nagpur HQ Nagpur, Maharashtra, India
Active Private Limited Company trading MSME · Micro
Data last updated
Revenue · FY 2017
₹3.08 Lakh
▲ 32% YoY
Net profit · FY 2017
₹25,795
Net margin 8.4%
EBITDA · FY 2017
₹31,946
EBITDA margin 10.4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
16 yrs
Est. 2010
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Macknoll Pharmaceuticals Private Limited

Data last updated:

Macknoll Pharmaceuticals Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 23 July 2010 and has been in existence for over 16 years.

The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U24239MH2010PTC205875. Its GSTIN is 27AAGCM7908L1ZY (Maharashtra).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Salman Ismail Bloch and Sakib Sandhi.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No. 19 Shrikrishna Nagar Wathoda Road, Nagpur, Maharashtra, India – 440008.

As per the financials filed for FY 2017, the company reported a revenue of ₹3.08 Lakh, a growth of 32% compared to the previous year. For the same year it recorded a net profit of ₹25,795 (net margin 8.4%) and EBITDA of ₹31,946 (EBITDA margin 10.4%).

Macknoll Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-20-0055148). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24239MH2010PTC205875
Registration Number 205875
Incorporation Date 23 July 2010
ROC Nagpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-20-0055148

Recognitions & Rankings of Macknoll Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-MH-20-0055148

Contact details

Macknoll Pharmaceuticals Private Limited's registered office is in Nagpur, Maharashtra. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Plot No. 19 Shrikrishna Nagar Wathoda Road, Nagpur, Maharashtra, India – 440008
  • Industry
    Trading, Wholesale, Other Wholesale

To see the full contact details of Macknoll Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Macknoll Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Macknoll Pharmaceuticals is agriculture, forestry, fishing. In detail, this covers support activities to agriculture and other activities including hunting.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
AAgriculture, forestry, fishingA4Support activities to agriculture and Other Activities including hunting

To see the full business activity and turnover split of Macknoll Pharmaceuticals Private Limited, buy the company report.

Financials of Macknoll Pharmaceuticals Private Limited

FY 2024 filings available

Macknoll Pharmaceuticals Private Limited reported revenue of ₹3.08 Lakh (up 32% YoY) for FY 2017.

Revenue · FY 2017
₹3.08 Lakh ▲ 32%
Net profit · FY 2017
₹25,795 margin 8.4%
EBITDA · FY 2017
₹31,946 margin 10.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 32%

Revenue rose 32% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2016-17FY 2015-16FY 2014-15
Profit and Loss Statement
Revenue from Operations₹3.08 Lakh
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹31,946
Profit Before Tax
Tax Expense
Net Profit (PAT)₹25,795
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2016-17FY 2015-16FY 2014-15
Profitability
EBITDA Margin10.4%
Net Profit Margin8.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Macknoll Pharmaceuticals Private Limited, buy the company report.

Board of directors of Macknoll Pharmaceuticals Private Limited

Macknoll Pharmaceuticals has 2 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Salman Ismail BlochDirector14 Mar 20251 Years 7 MonthsCurrent
Sakib SandhiDirector14 Mar 20251 Years 7 MonthsCurrent

Auditor

Macknoll Pharmaceuticals Private Limited is audited by Prem Gopalani & Co. for the financial year 2017.

Auditor firmFinancial yearFirm registration number
Prem Gopalani & Co.FY 2017129281W

Shareholding

The shareholding of Macknoll Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016FY 2015
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Macknoll Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Macknoll Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Macknoll Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAGCM7908L1ZYMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Macknoll Pharmaceuticals Private Limited, buy the company report.

Recent activity

Macknoll Pharmaceuticals Private Limited has 10 board changes on record since 2019: 2 appointments and 8 cessations. The latest: Mohammed Idrish Yusufbhai Shaikh ceased to be Director on 21 Mar 2025.

Ceased
Mohammed Idrish Yusufbhai Shaikh ceased to be Director.
Ceased
Sureshkumar Mohanlal Prajapati ceased to be Director.
Appointed
Sakib Sandhi was appointed as Director.
Appointed
Salman Ismail Bloch was appointed as Director.
AGM
Macknoll Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Hafiz Beg Rustam Beg Mirza ceased to be Director.
Ceased
Mohammadmunaf Shaikh ceased to be Director.
Ceased
Niraj Gajananrao Yedaskar ceased to be Director.
Ceased
Rajesh Shrikrishnarao Lokhande ceased to be Director.
Ceased
Shekh Mo Soeb ceased to be Director.
Filing
Macknoll Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Nagpur.
Ceased
Sunil Pyarelal Zalpure ceased to be Director.

1 earlier event is in the company report.

Frequently asked questions

Macknoll Pharmaceuticals is an active private limited company based in Nagpur, Maharashtra, India. The company works in wholesale, within the trading industry. It was incorporated on 23 July 2010 (16+ years old) and is registered under CIN U24239MH2010PTC205875.

Macknoll Pharmaceuticals has 2 current directors:

The latest financial statements of Macknoll Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Macknoll Pharmaceuticals is 27AAGCM7908L1ZY, registered in Maharashtra.

The CIN (Corporate Identification Number) of Macknoll Pharmaceuticals is U24239MH2010PTC205875. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Macknoll Pharmaceuticals was incorporated on 23 July 2010, making it 16+ years old. It is registered with the Registrar of Companies, Nagpur.

Mohammed Idrish Yusufbhai Shaikh ceased to be Director on 21 Mar 2025. Sureshkumar Mohanlal Prajapati ceased to be Director on 21 Mar 2025. Sakib Sandhi was appointed as Director on 14 Mar 2025. Macknoll Pharmaceuticals has 10 board changes on record in total.

Yes, Macknoll Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-20-0055148).

The registered office of Macknoll Pharmaceuticals is at Plot No. 19 Shrikrishna Nagar Wathoda Road, Nagpur, Maharashtra, India – 440008.

Macknoll Pharmaceuticals operates in the trading industry, in the wholesale segment.